<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig9" orientation="portrait" position="float">
 <label>Figure 9</label>
 <caption>
  <p>The novel THA-adamantanamines 
   <bold>26</bold> and 
   <bold>27</bold> acting as ChE inhibitors and NMDAR antagonists. Also, tacripyrimidines with general structure 
   <bold>28</bold> are here represented as agents influencing Ca
   <sup>2+</sup> influx and intracellular concentration by blocking voltage-gated Ca
   <sup>2+</sup> channels.
  </p>
 </caption>
 <graphic xlink:href="BMRI2020-5120230.009" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
